# Impact of a Monitoring Device for Patients With Cancer Treated Using Oral Therapeutics

> **NCT02828462** · — · UNKNOWN · sponsor: **Gustave Roussy, Cancer Campus, Grand Paris** · enrollment: 1000 (estimated)

## Conditions studied

- Metastatic Cancer
- Hematological Malignancy

## Interventions

- **OTHER:** CAPRI

## Key facts

- **NCT ID:** NCT02828462
- **Lead sponsor:** Gustave Roussy, Cancer Campus, Grand Paris
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-10-24
- **Primary completion:** 2019-10
- **Final completion:** 2020-10
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2018-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02828462

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02828462, "Impact of a Monitoring Device for Patients With Cancer Treated Using Oral Therapeutics". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT02828462. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*